Silverfleet Capital has promoted Alfa Chan, David Mackenzie and Joachim Braun to partners. Also, the European private equity firm also said that Adam Ahern will be joining as an associate at the end of the month.
2 September 2015 – Silverfleet Capital, the European private equity firm, has today announced that Alfa Chan, David Mackenzie and Joachim Braun have been promoted to partners in the firm. In addition, Adam Ahern will also be joining the firm at the end of September as an associate in the London office.
These promotions and appointment demonstrate the firms commitment to strengthening the team as it continues to deploy its new €870 million* second fund, following the successful fundraising of Silverfleet Capital Partners II, which closed in May 2015.
Alfa Chan and David Mackenzie are both based in London and have been with Silverfleet Capital for thirteen years and eleven years respectively, working across transactions within the healthcare and manufacturing sectors, roles that they will continue as partners. Joachim Braun, is based in Munich and has been with the firm for eight years. He will become a second partner in Silverfleet’s Munich office and will continue to focus on investment activities in the DACH region.
Adam Ahern will be joining the firm from Greenhill & Co where he worked in the M&A department. Adam has a degree in Business & Economics from Trinity College Dublin.
Neil MacDougall, managing partner of Silverfleet Capital commented: “I would like to welcome Alfa, David and Joachim into the partnership at Silverfleet Capital. They have each made significant contributions to the success of our firm and we wish them every success in their new roles as we deploy our €870 million second fund.
“These promotions continue our tradition of promoting from within as well as attracting talented individuals such as Adam from outside of our firm. It also demonstrates our continued commitment to developing strong investment teams in each of our offices across Europe.”
* The higher current fund size includes the commitments made by the Silverfleet Capital team.
– Ends –
For further information please contact:
UK – Equity Dynamics
Corinna Osborne – +44 7825 326 440
Germany – Ira Wülfing Kommunikation
Ira Wülfing – +49 89 2000 3030
France – Kablé Communication Finance
Hélène Fritz – +33 1 44 50 54 71
Notes to editors:
About Silverfleet Capital
Silverfleet Capital has been an active European mid-market private equity investor for 30 years and currently manages around €1.6 billion. A network of offices in London, Munich and Paris enables Silverfleet Capital to execute complex, multi-jurisdictional investments and then achieve value creation through its “buy-to-build” investment strategy. This investment strategy means working with companies to create value by accelerating their growth through investment in new products, production capacity or people, or rolling out successful retail formats or through making follow-on acquisitions. Since 1990 Silverfleet Capital has invested more than €3 billion in 116 businesses.
Silverfleet focuses on four sectors: business & financial services, healthcare, manufacturing and retail, leisure & consumer products. Over the last ten years 32% of invested capital has been invested in businesses headquartered in Germany, 26% in the UK, 25% in the Nordic region and 17% elsewhere mainly in France and the Benelux. Silverfleet’s existing portfolio includes well-known brands such as OFFICE, the young fashion footwear retailer, La Fée Maraboutée, a wholesaler & retailer of women’s fashion and most recently Masai Clothing Company, the Denmark-headquartered international wholesaler and retailer of women’s fashion. Kalle, the producer of artificial sausages casings, Cimbria, a seed & grain processing equipment manufacturer and Ipes, the fund administrator and service provider focused on private equity are examples of other current portfolio companies.
Silverfleet Capital has a consistently strong investment track record. Most recently Silverfleet successfully exited Aesica, the leading pharmaceutical CDMO business (3.3x cost). Other notable exits include Sterigenics International Inc., the world’s leading medical device sterilization company*, Histoire d’Or, the European jewellery retailer (3.2x cost), TMF, the global independent administrators (6.1x cost) and Phadia, the world’s leading allergy diagnostics company (4.8x cost).